Article
Irvine, CA-Refractec Inc. has filed its pre-market approval application with the FDA for a conductive keratoplasty (CK) procedure designed for patients with presbyopia.
US News & World Report releases list of best ophthalmology ambulatory surgical centers in the US
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
FDA approves expanded label for fluocinolone acetonide intravitreal implant
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Innovent Biologics announces approval of SYCUME in China for thyroid eye disease
Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE